Sudipto Mukherjee, MD, Oncology, Cleveland, OH, Cleveland Clinic

SudiptoMukherjeeMDPhD, MPH

Oncology Cleveland, OH

Hematologic Oncology

Staff, Cleveland Clinic Taussig Cancer Institute

Dr. Mukherjee is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mukherjee's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology/Oncology, 2010 - 2013
  • William Beaumont Hospital
    William Beaumont HospitalResidency, Internal Medicine, 2007 - 2010
  • University of Alabama at BirminghamPhD, vision Science, 2002 - 2007
  • University of Alabama at BirminghamMPH, Epidemiology and Biostatistics, 2001 - 2004
  • NRS Medical College Calcutta
    NRS Medical College CalcuttaClass of 1996

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2010 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease  
    Aaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood

Abstracts/Posters

  • Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
    Sudipto Mukherjee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid Neoplasia
    Sudipto Mukherjee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
    Sudipto Mukherjee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Real-World Treatment Patterns and Transfusion Burden Among US Patients with Newly Diagnosed Myelodysplastic Syndromes (MDS) 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Special Education Session on ASH Clinical Practice Guidelines on Acute Myeloid Leukemia in Older Adults 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Join now to see all

Press Mentions

  • Clinical Challenge: Discontinuing TKIs in Chronic Phase CML
    Clinical Challenge: Discontinuing TKIs in Chronic Phase CMLJuly 7th, 2019
  • Cancer Treatment May Elevate Risk of Acute Lymphoblastic Leukemia
    Cancer Treatment May Elevate Risk of Acute Lymphoblastic LeukemiaMay 13th, 2019
  • Treatment Guidelines Established for Idiopathic Multicentric Castleman Disease
    Treatment Guidelines Established for Idiopathic Multicentric Castleman DiseaseDecember 19th, 2018
  • Join now to see all

Other Languages

  • Bengali, Hindi

Hospital Affiliations